Dyne Therapeutics, Inc. (DYN)

NASDAQ: DYN · Real-Time Price · USD

21.17

+0.37 (1.78%)

Nov 26, 2025, 4:00 PM EST - Market closed

Dyne Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Nov '25 Nov 26, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	3,024	2,398	816	604	606	954	Upgrade
Market Cap Growth	7.06%	193.72%	35.12%	-0.32%	-36.50%	-	Upgrade
Enterprise Value	2,352	1,699	687	387	233	585	Upgrade
Last Close Price	21.17	23.56	13.30	11.59	11.89	21.00	Upgrade
PB Ratio	4.36	3.81	8.94	2.39	1.65	2.79	Upgrade
P/TBV Ratio	4.37	3.81	8.94	2.39	1.65	2.79	Upgrade
Debt / Equity Ratio	0.17	0.04	0.30	0.12	0.09	-	Upgrade
Quick Ratio	13.23	15.20	2.41	9.12	13.11	31.49	Upgrade
Current Ratio	13.47	15.60	2.53	9.46	13.31	31.83	Upgrade
Return on Equity (ROE)	-60.66%	-88.03%	-137.31%	-54.18%	-42.02%	-33.35%	Upgrade
Return on Assets (ROA)	-34.32%	-50.20%	-64.21%	-29.20%	-24.07%	-19.82%	Upgrade
Return on Capital (ROIC)	-36.39%	-55.64%	-75.38%	-31.26%	-25.23%	-20.57%	Upgrade
Return on Capital Employed (ROCE)	-55.60%	-53.00%	-212.40%	-61.40%	-37.80%	-17.10%	Upgrade
Earnings Yield	-14.02%	-13.24%	-28.90%	-27.82%	-24.63%	-6.23%	Upgrade
FCF Yield	-13.13%	-12.29%	-23.14%	-25.94%	-20.33%	-5.00%	Upgrade
Buyback Yield / Dilution	-39.30%	-57.74%	-14.83%	-2.13%	-253.54%	-489.30%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q